Announced Tue, 5 May · 18:13 IST
Board Approves Final Dividend for the FY 2025-26
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.3%1-day move
₹42.11
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-5.3-6.7-7.4-8.7-11.4-8.6+4.5-0.2-1.2—
Up moveDown movePending
AI summary
The Board of Directors of Sandu Pharmaceuticals Limited has recommended a final dividend of Rs. 1 per equity share for the financial year 2025-26. The dividend is for shares held as of March 31, 2026. This recommendation is subject to approval by shareholders at the upcoming Annual General Meeting. The company will announce the record date and dividend payout date in due course.
Likely market impact
Shareholders can expect a modest dividend payout if approved at the AGM. The small amount of Rs. 1 per share suggests a low dividend yield, which may have minimal positive impact on the stock price.